Archive

The word ‘Cancer’ looms fear and anxiety in the minds of the general public. The insidious onset and the possible devastative outcome which this disease can bring about, makes it one of the most dreaded diseases by mankind. However today, this perception is slowly declining adding a ray of hope into the lives of cancer […]

The Covid-19 pandemic has brought in unique challenges to the clinical trial industry world over. Overall there have been substantial changes to healthcare access, health risks and daily interactions causing concern over the conduct of clinical trials during this period. The government bodies have greatly restricted the movement of public, by enacting laws to ensure […]

The field of oncology has progressively refined over the past two decades with the advancement of in-depth, targeted therapies. This has led to an overall increase in the survival rates of cancer patients and improvements in quality of life. However, globally there is a low participation of cancer patients in clinical studies and many new […]

Rare diseases are complex and perplexing to medical science. The low prevalence, diversity and limited knowledge, makes it very challenging to recruit subjects into a clinical trial. Rare diseases adds a significant burden on mankind with 80% of rare diseases being genetic in nature and 50% of these conditions being diagnosed in children.In Japan too, […]

The word ‘cancer’ looms fear and uncertainty in the minds of people. This statement has a certain degree of validation with cancer having advanced as the number one cause of fatality in Japan. Although cancer mortality has declined in the young population, the mortality rates have significantly risen among the elderly population. The last decade […]

Every subject adds value to a clinical trial. Patient recruitment and retention are key aspects for the successful completion of a clinical trial. A high dropout rate can lead to a wastage of time, money and effort where any pharmaceutical company will not be able to gather prime data of primary outcomes in a clinical […]

Engaging in clinical trials from the comfort of home is music to the ears of patients. Though talks on conducting clinical trials virtually has been present, the disruption by Covid -19 has rapidly made virtual trials a reality. The pandemic raised concerns on conducting clinical trials safely without suspending or postponing patient visits to ensure […]

The optimal functioning of genes in our body is essential for our wellbeing. However, there is a probability that we might inherit a defective gene which codes for a certain illness. This is sure to leave you frustrated. Not anymore though – gene therapy is advancing rapidly to prevent and treat such disabilities. Through unending […]

The clinical research industry thrives on efficient patient recruitment and retention. One of the most challenging aspects in a randomised controlled trial is reaching the set target patient population. Poor recruitment figures questions the financial and scientific viability of a clinical trial. If the estimated sample size of a clinical trial is not met, then […]

3H Medi Solution is continuously trying to adopt novel ways to make Clinical trial conduct more efficient and innovative. This has brought about a new facelift to the industry in Japan, with bio-pharma companies being open to having the general population participate in the trial process in formulating protocols and generating data. 3H as a […]